Eric co-founded Averin leveraging his experience as an executive who can scale organizations efficiently and effectively with the aspiration of harnessing the power of technology to transform health.

Eric was the founder and CEO of TripleLift, an AI-focused tech platform. He led the company from inception, raising only $16M in outside capital before selling a majority of the business to Vista Equity Partners for over $1.4B, one of the largest cash-on-cash returns in the history of New York tech. TripleLift was consistently a highly profitable ​“rule of” 70+ company, growing to well over $200M in revenue, operating across a dozen countries, while also executing 9‑digit cross-border M&A.  

Eric has been recognized as a highly successful entrepreneur, including as an EY Entrepreneur of the Year, along with several 40 under 40 awards. TripleLift was recognized by Inc. 5000 and Deloitte Fast 500 as being among the fastest growing companies in America for six consecutive years, while also regularly winning ​“Best Places to Work” awards from numerous publications. 

Eric received his bachelor’s and master’s degrees from MIT in computer science and electrical engineering, focusing on biomedical engineering, and his J.D. from NYU School of Law. At MIT, Eric was among the group that completed the first ever comparative sequencing and analysis of two mammal genomes, including being published in a Nature cover article.